Rafferty Asset Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $630K | Sell |
181,957
-23,111
| -11% | -$80K | ﹤0.01% | 841 |
|
|
2025
Q1 | $537K | Sell |
205,068
-44,493
| -18% | -$117K | ﹤0.01% | 851 |
|
|
2024
Q4 | $1.03M | Buy |
249,561
+69,531
| +39% | +$286K | ﹤0.01% | 787 |
|
|
2024
Q3 | $1.27M | Sell |
180,030
-13,902
| -7% | -$98.4K | ﹤0.01% | 748 |
|
|
2024
Q2 | $1.26M | Sell |
193,932
-270,128
| -58% | -$1.76M | ﹤0.01% | 760 |
|
|
2024
Q1 | $3.85M | Buy |
464,060
+136,512
| +42% | +$1.13M | 0.01% | 524 |
|
|
2023
Q4 | $3.61M | Sell |
327,548
-50,197
| -13% | -$553K | 0.02% | 513 |
|
|
2023
Q3 | $3.18M | Sell |
377,745
-249,268
| -40% | -$2.1M | 0.02% | 489 |
|
|
2023
Q2 | $7.88M | Buy |
627,013
+183,387
| +41% | +$2.3M | 0.04% | 289 |
|
|
2023
Q1 | $7.31M | Sell |
443,626
-30,653
| -6% | -$505K | 0.05% | 275 |
|
|
2022
Q4 | $7.09M | Buy |
474,279
+278,160
| +142% | +$4.16M | 0.06% | 295 |
|
|
2022
Q3 | $4.39M | Buy |
196,119
+14,021
| +8% | +$314K | 0.05% | 357 |
|
|
2022
Q2 | $3.05M | Buy |
182,098
+11,824
| +7% | +$198K | 0.03% | 384 |
|
|
2022
Q1 | $5.1M | Sell |
170,274
-19,728
| -10% | -$590K | 0.03% | 389 |
|
|
2021
Q4 | $5.84M | Buy |
190,002
+92,906
| +96% | +$2.85M | 0.03% | 317 |
|
|
2021
Q3 | $3.06M | Buy |
97,096
+20,871
| +27% | +$658K | 0.02% | 469 |
|
|
2021
Q2 | $2.79M | Sell |
76,225
-8,584
| -10% | -$314K | 0.02% | 531 |
|
|
2021
Q1 | $2.93M | Buy |
84,809
+73,840
| +673% | +$2.55M | 0.02% | 509 |
|
|
2020
Q4 | $456K | Buy |
+10,969
| New | +$456K | ﹤0.01% | 701 |
|